COVID-19 and dexamethasone-induced hyperglycaemia: Workload implications for diabetes inpatient teams

被引：2
|
作者：
Younes, Younes R. [1 ]
Stockley, Susan [1 ]
Keegan, Lorna [1 ]
O'Donoghue, Linda [1 ]
Yohannan, Elizabeth [1 ]
Read, Liz [1 ]
Williamson, Jamie-Leigh [1 ]
Peter, John [1 ]
Lakshmipathy, Kavitha [1 ]
Smout, Vera [1 ]
Nayyar, Vidhu [1 ]
Emmanuel, Julian [1 ]
Zachariah, Sunil [1 ]
Clark, James [1 ]
Field, Benjamin C. T. [1 ,2 ]
机构：
[1] East Surrey Hosp Surrey & Sussex Healthcare NHS T, Redhill, Surrey, England
[2] Univ Surrey, Fac Hlth & Med Sci, Sect Clin Med, Guildford, Surrey, England
来源：
DIABETIC MEDICINE | 2022年 / 39卷 / 02期
关键词：
D O I：
10.1111/dme.14716
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes
    Rayman, G.
    Lumb, A. N.
    Kennon, B.
    Cottrell, C.
    Nagi, D.
    Page, E.
    Voigt, D.
    Courtney, H. C.
    Atkins, H.
    Higgins, K.
    Platts, J.
    Dhatariya, K.
    Patel, M.
    Newland-Jones, P.
    Narendran, P.
    Kar, P.
    Burr, O.
    Thomas, S.
    Stewart, R.
    DIABETIC MEDICINE, 2021, 38 (01)
  • [22] Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia
    Laurenzi, Andrea
    Caretto, Amelia
    Molinari, Chiara
    Bazzigaluppi, Elena
    Brigatti, Cristina
    Marzinotto, Ilaria
    Mercalli, Alessia
    Melzi, Raffaella
    Nano, Rita
    Tresoldi, Cristina
    Landoni, Giovanni
    Ciceri, Fabio
    Lampasona, Vito
    Scavini, Marina
    Piemonti, Lorenzo
    BIOLOGY-BASEL, 2021, 10 (08):
  • [23] Dexamethasone nanomedicines for COVID-19
    Twan Lammers
    Alexandros Marios Sofias
    Roy van der Meel
    Raymond Schiffelers
    Gert Storm
    Frank Tacke
    Steffen Koschmieder
    Tim H. Brümmendorf
    Fabian Kiessling
    Josbert M. Metselaar
    Nature Nanotechnology, 2020, 15 : 622 - 624
  • [24] Dexamethasone as a Treatment of COVID-19
    Abdullah Alkattan
    Mahmoud Kandeel
    Dr. Sulaiman Al Habib Medical Journal, 2021, 3 (1) : 7 - 9
  • [25] Dexamethasone in the management of covid-19
    Johnson, Raymond M.
    Vinetz, Joseph M.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [26] Dexamethasone nanomedicines for COVID-19
    Lammers, Twan
    Sofias, Alexandros Marios
    van der Meel, Roy
    Schiffelers, Raymond
    Storm, Gert
    Tacke, Frank
    Koschmieder, Steffen
    Bruemmendorf, Tim H.
    Kiessling, Fabian
    Metselaar, Josbert M.
    NATURE NANOTECHNOLOGY, 2020, 15 (08) : 622 - 624
  • [27] Current Practices in Monitoring Dexamethasone-Induced Hyperglycemia on an Inpatient Palliative Care Unit
    Bach, Tammy
    Karuza, Jurgis
    Berall, Anna
    Kassam, Altaf
    Perri, Giulia-Anna
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 52 (06) : E118 - E118
  • [28] The benefit of dexamethasone in patients with COVID-19 infection is preserved in patients with diabetes
    Eng, Pei Chia
    Distaso, Walter
    Durreshahwar, Hashmi
    Shaikhali, Yusuf
    Narendranathan, Divani
    Cassin-Scott, Rebecca
    Misra, Shivani
    Hill, Neil E.
    Tharakan, George
    Oliver, Nick S.
    Tan, Tricia M.
    Izzi-Engbeaya, Chioma
    Salem, Victoria
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1385 - 1389
  • [29] Nursing workload in the COVID-19 era
    Lucchini, Alberto
    Iozzo, Pasquale
    Bambi, Stefano
    INTENSIVE AND CRITICAL CARE NURSING, 2020, 61
  • [30] COVID-19 induced Diabetes: A novel presentation
    Joshi, Samruddhi Chandrashekhar
    Pozzilli, Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
12345